Table 3 |
|||||
|
Chikungunya self-reported symptoms × serological status in the community. |
|||||
|
Population-based survey, Reunion Island outbreak, August – October 2006 (post-epidemic era) |
|||||
|
|
|||||
|
Symptoms |
Negative serology |
Positive serology * |
Total |
||
|
|
|
|
|
||
|
Arthralgia |
111 |
(12.6) |
770 |
(87.4) |
881 |
|
Fever |
92 |
(10.9) |
753 |
(89.1) |
845 |
|
Asthenia |
89 |
(12.8) |
605 |
(87.2) |
694 |
|
Headache |
69 |
(11.2) |
545 |
(88.8) |
614 |
|
Myalgia |
68 |
(12.0) |
497 |
(88.0) |
565 |
|
Rash |
41 |
(7.7) |
493 |
(92.3) |
534 |
|
Pruritus |
36 |
(7.9) |
421 |
(92.1) |
457 |
|
Vomiting |
31 |
(14.2) |
188 |
(85.8) |
219 |
|
Diarrhea |
21 |
(13.5) |
135 |
(86.5) |
156 |
|
Depression |
19 |
(13.2) |
125 |
(86.8) |
144 |
|
Fever and arthralgia |
89 |
(13.0) |
594 |
(87.0) |
683 |
|
Total |
118 |
(100) |
805 |
(100) |
923 |
|
|
|||||
|
Data are numbers of persons questioned and (row) percentages. Positive Predictive value (PPV) * |
|||||
|
Gérardin et al. BMC Infectious Diseases 2008 8:99 doi:10.1186/1471-2334-8-99 |
|||||
